{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:57:52Z","timestamp":1778511472792,"version":"3.51.4"},"reference-count":18,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100004621","name":"Deputy of Research, Kerman University of Medical Sciences","doi-asserted-by":"publisher","award":["95000662"],"award-info":[{"award-number":["95000662"]}],"id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCP"],"published-print":{"date-parts":[[2019,12,31]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Serotonin 5-HT3 receptor antagonists such as ondansetron have been investigated\nto attenuate opioid withdrawal signs in studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Therefore, we designed a randomized double-blinded placebo-controlled trial to evaluate\nthis effect on opioid-addicted patients who were admitted to the orthopedic department for surgery\ndue to bone fractures.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Male adults who were addicted to opioids, aged 18 to 79 years were enrolled (n=96) and\nrandomized into intravenous doses (4 &amp; 8 mg) of ondansetron (n=32) and placebo (n=32). The vital\nsigns, withdrawal symptoms and the frequency requirement of fentanyl were recorded during anesthesia,\nand opioid (pethidine) analgesic was received during the recovery period. Outcome parameters\nwere analyzed for reduction of withdrawal symptoms in addicted adults.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>We indicated that ondansetron demonstrated significant differences with few vital outcomes\nincluding systolic blood pressure (SBP) 20 (SBP3) and 50 min (SBP4) after injection of\nondansetron during the period of surgery. Ondansetron could also significantly reduce the frequency\nrequirement of fentanyl at 20 min (dose 3) in general anesthesia. Furthermore, requirement\nfor further administration of opioid analgesic drugs such as pethidine was significantly reduced in\nthe ondansetron groups. Objective opioid withdrawal scale (OOWS) results indicated that few clinical\nparameters including tremor, hot and cold flushes and anxiety were significantly attenuated in\naddicted patients who received ondansetron.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study demonstrated supporting evidence for the beneficial treatment of ondansetron\nfor the control of withdrawal symptoms and pain in addicted patients, and more clinical studies\nare suggested in this regard.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574884714666190131122846","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T06:16:09Z","timestamp":1549001769000},"page":"232-241","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Ondansetron on Withdrawal Signs, Fentanyl Requirement and Pain Relief in Opioid-addicted Patients under General Anesthesia"],"prefix":"10.2174","volume":"14","author":[{"given":"Farzaneh","family":"Mahikhan","sequence":"first","affiliation":[{"name":"Department of Toxicology and Pharmacology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Hashemian","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Dehesh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Jafari","sequence":"additional","affiliation":[{"name":"Pathology and Stem Cells Research Center, Kerman University of Medical Science, Kerman, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandana","family":"Jafari","sequence":"additional","affiliation":[{"name":"Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid-Reza","family":"Rahimi","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Pharmacology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.2174\/138161281941131219130127","volume":"19","author":"Leppert W.","year":"2013","unstructured":"Leppert W.; Krajnik M.; Wordliczek J.; Delivery systems of opioid analgesics for pain relief: A review. Curr Pharm Des 2013,19(41),7271-7293","journal-title":"Curr Pharm Des"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4103\/0973-1075.191742","volume":"22","author":"Saini S.","year":"2016","unstructured":"Saini S.; Bhatnagar S.; Cancer pain management in developing countries. Indian J Palliat Care 2016,22(4),373-377","journal-title":"Indian J Palliat Care"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.lfs.2013.09.016","volume":"93","author":"Podolsky A.T.","year":"2013","unstructured":"Podolsky A.T.; Sandweiss A.; Hu J.; Novel fentanyl-based dual \u03bc\/\u03b4-opioid agonists for the treatment of acute and chronic pain. Life Sci 2013,93(25-26),1010-1016","journal-title":"Life Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2344\/0003-3006(2005)52[140:DTD]2.0.CO;2","volume":"52","author":"Becker DE","year":"2005","unstructured":"Becker DE; Phero JC; Drug therapy in dental practice: Nonopioid and opioid analgesics. Anesth Prog 2005,52(4),140-9","journal-title":"Anesth Prog"},{"key":"ref=5","first-page":"677","volume":"18","author":"Roychoudhury M.","year":"1996","unstructured":"Roychoudhury M.; Kulkarni S.K.; Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist. Methods Find Exp Clin Pharmacol 1996,18(10),677-683","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0014-2999(97)01349-6","volume":"340","author":"Pinelli A.","year":"1997","unstructured":"Pinelli A.; Trivulzio S.; Tomasoni L.; Effects of ondansetron administration 1 Zofran is the trade name for ondansetron (injectable solution) manufactured by Glaxo Sp A, Verona, Italy. 1 on opioid withdrawal syndrome observed in rats. Eur J Pharmacol 1997,340,111-119","journal-title":"Eur J Pharmacol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/anae.13112","volume":"70","author":"Kidd L.R.","year":"2015","unstructured":"Kidd L.R.; Milner Q.J.; Paracetamol and unwanted 5-hydroxytryptamine interactions. Anaesthesia 2015,70(6),757-758","journal-title":"Anaesthesia"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/j.1476-5381.1993.tb13966.x","volume":"110","author":"Hui S.C.","year":"1993","unstructured":"Hui S.C.; Sevilla E.L.; Ogle C.W.; 5-HT3 antagonists reduce morphine self-administration in rats. Br J Pharmacol 1993,110(4),1341-1346","journal-title":"Br J Pharmacol"},{"key":"ref=9","first-page":"444","volume":"80","author":"Papadopoulos G.","year":"2014","unstructured":"Papadopoulos G.; Pouangare M.; Papathanakos G.; Arnaoutoglou E.; Petrou A.; Tzimas P.; The effect of ondansetron on postoperative delirium and cognitive function in aged orthopedic patients. Minerva Anestesiol 2014,80(4),444-451","journal-title":"Minerva Anestesiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.11124\/jbisrir-2015-1768","volume":"13","author":"Badeaux J.","year":"2015","unstructured":"Badeaux J.; Bonanno L.; Au H.; Effectiveness of ondansetron as an adjunct to lidocaine intravenous regional anesthesia on tourniquet pain and postoperative pain in patients undergoing elective hand surgery: A systematic review protocol. JBI Database Syst Rev Implement Reports 2015,13(1),27-38","journal-title":"JBI Database Syst Rev Implement Reports"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/10550887.2014.882727","volume":"33","author":"Salimi A.","year":"2014","unstructured":"Salimi A.; Safari F.; Mohajerani S.A.; Hashemian M.; Kolahi A.A.; Mottaghi K.; Long-term relapse of ultra-rapid opioid detoxification. J Addict Dis 2014,33(1),33-40","journal-title":"J Addict Dis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/EJA.0000000000000347","volume":"32","author":"Roelants F.","year":"2015","unstructured":"Roelants F.; Lavand\u2019homme P.; Clonidine versus sufentanil as an adjuvant to ropivacaine in patient-controlled epidural labour analgesia: A randomised double-blind trial. Eur J Anaesthesiol 2015,32(11),805-811","journal-title":"Eur J Anaesthesiol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5125\/jkaoms.2016.42.2.84","volume":"42","author":"Savant K.","year":"2016","unstructured":"Savant K.; Khandeparker R.V.; Berwal V.; Khandeparker P.V.; Jain H.; Comparison of ondansetron and granisetron for antiemetic prophylaxis in maxillofacial surgery patients receiving general anesthesia: A prospective, randomised, and double blind study. J Korean Assoc Oral Maxillofac Surg 2016,42(2),84-89","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"FC10","DOI":"10.7860\/JCDR\/2017\/25129.9818","volume":"11","author":"Parathoduvil A.A.","year":"2017","unstructured":"Parathoduvil A.A.; Sisupalan A.; Rema P.L.; Comparison of antiemetic effectiveness of palonosetron versus ondansetron in patients on cancer chemotherapy: A prospective observational study in South Indians. J Clin Diagn Res 2017,11(5),FC10-FC14","journal-title":"J Clin Diagn Res"},{"key":"ref=15","first-page":"332","volume":"33","author":"Owczuk R.","year":"2008","unstructured":"Owczuk R.; Wenski W.; Polak-Krzeminska A.; Ondansetron given intravenously attenuates arterial blood pressure drop due to spinal anesthesia: A double-blind, placebo-controlled study. Reg Anesth Pain Med 2008,33(4),332-339","journal-title":"Reg Anesth Pain Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/0019-5049.174810","volume":"60","author":"Sumalatha G.B.","year":"2016","unstructured":"Sumalatha G.B.; Dodawad R.R.; Pandarpurkar S.; Jajee P.R.; A comparative study of attenuation of propofol-induced pain by lignocaine, ondansetron, and ramosetron. Indian J Anaesth 2016,60(1),25-29","journal-title":"Indian J Anaesth"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s40122-012-0004-5","volume":"1","author":"Wakim J.H.","year":"2012","unstructured":"Wakim J.H.; Alleviating symptoms of withdrawal from an opioid. Pain Ther 2012,1(1),4","journal-title":"Pain Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/ADM.0000000000000321","volume":"11","author":"Chu L.F.","year":"2017","unstructured":"Chu L.F.; Sun J.; Clemenson A.; Ondansetron does not reduce withdrawal in patients with physical dependence on chronic opioid therapy. J Addict Med 2017,11(5),342-349","journal-title":"J Addict Med"}],"container-title":["Current Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T10:27:43Z","timestamp":1581071263000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169510\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,12,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574884714666190131122846","relation":{},"ISSN":["1574-8847"],"issn-type":[{"value":"1574-8847","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-09-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}